Answers are grounded in this paper and cite their sources.
Background Cerebral small vessel disease (CSVD) is the primary cause of vascular cognitive impairment (VCI). It is characterized by mild cognitive impairment (MCI) in the early stages, but MCI is difficult to detect. The CSVD burden is an imaging marker; however, the diagnostic sensitivity and specificity for CSVD-MCI are not high. It is not clear whether the virtual reality eye-tracking cognitive assessment (VECA) can make up for this deficiency. Objective To explore the application value of total CSVD burden combined with VECA in the identification of CSVD-MCI. Methods We included 143 patients with CSVD in this cross-sectional study; all were treated at Suzhou Hospital Affiliated to Anhui Medical University from March 2025 to June 2026. According to the inclusion and exclusion criteria and the guidelines for the diagnosis and treatment of MCI, patients were divided into the CSVD normal cognition (CSVD-NC) group ( n = 72) and the CSVD mild cognitive impairment (CSVD-MCI) group ( n = 71). Clinical data, cognitive function scores on traditional scales (including the mini-mental state examination [MMSE] and Montreal cognitive assessment [MoCA]), MRI features, and VECA scores were collected and compared between the two groups. Receiver operating characteristic (ROC) analysis was used to assess the diagnostic efficacy of the virtual reality (VR) total score, the total CSVD burden score, and the combined model (CSVD burden + VR score) for CSVD-MCI. Results The VECA scores of patients in the CSVD-MCI group were significantly lower than those in the CSVD-NC group, with impairments across multiple cognitive domains, including executive function, attention, abstraction, memory, and calculation. The combined use of the VR total score and the CSVD burden yielded an AUC of 0.914 (95% confidence interval [CI]: 0.855–0.954) for diagnosing CSVD-MCI, with a sensitivity of 87.1% and a specificity of 80.6%. Conclusion Virtual reality eye-tracking cognitive assessment may improve the diagnostic value of the CSVD burden for identifying CSVD-MCI; prospective longitudinal studies are needed to confirm whether it enables earlier detection of cognitive decline.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: